Comparing a new surgery to a diabetes drug for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial compares a new surgical procedure (duodeno-ileostomy) to a medication (semaglutide) for people with obesity and type 2 diabetes. It aims to see which approach works better for weight loss and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a body mass index (BMI) between 30 and 40, meaning you have obesity and need treatment.
- You have type 2 diabetes, confirmed by a recent blood test (HbA1c of 6.5% or higher).
- You are willing to be randomly assigned to either surgery or medication.
- You agree not to have any other weight-loss surgery or take other weight-loss drugs during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.
This trial tests a new procedure that uses magnets to reroute part of your small intestine. It is for people with type 2 diabetes or who have had a sleeve gastrectomy and gained weight back. The goal is to see if this magnetic treatment can help with weight loss and diabetes control.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This trial tests whether a specific type of weight loss surgery can help people with type 2 diabetes stop needing diabetes medication. It is for people with a very high body mass index (BMI over 45) who are currently on diabetes pills or insulin.
This study tests a new injectable medication (NNC0662-0419) designed to help people with obesity lose weight. Researchers are comparing different ways of increasing the dose to find the safest and most effective approach.
Hear when a new Obesity (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.